Orlando Immunology Center   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Orlando FL United States

Organization Overview

First Clinical Trial
2006
NCT00312039
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Charlotte-Paige Rolle, MD | Orlando Immunology Center